Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs
SEATTLE and CAMBRIDGE, United Kingdom, April 05, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company...